Klinische Studie
Comprehensive assessment of clinical features and biomarkers to identify patients with advanced or metastatic breast cancer for marker driven trials in humans (CATCH)(CATCH)Implementierung der Präzisions-Onkologie beim metastasiertem Mammakarzinom
Krankheitsentität(en)
Brust
Wesentliche Einschlusskriterien- Female and male breast cancer patients aged ≥18 years (or if the legal guardian has agreed to the respective consent form)
- Patients with locally advanced (including local relapses) or metastatic breast cancer not amendable to curative treatment (irrespective of clinical parameters such as TNM, breast cancer subgroups (LumA/B, TNBC, HER2) and metastatic site)
- Patients can be enrolled in the study at any line of treatment (e.g. 1st, 2nd, or ≥ 3rd line) at a) initial diagnosis of metastasis or b) at any time point of progress
- ECOG ≤ 2
- Provision of informed consent form (ICF)
Wesentliche Ausschlusskriterien- Inability to retrieve a fresh tissue sample at the time point of metastasis or progress due to reasons such as physical location of the lesion or health of the patient and archival material for evaluation from the time point of progress taken prior to current treatment line initiation not available.
- Any physical or mental handicap or severe comorbidities that would hamper the adequate cooperation with the patient.
Statusrekrutierend
Ansprechpartner & KontaktCaritas-Krankenhaus St. Josef RegensburgFrauenheilkunde und Geburtshilfe Krankenhaus St JosefStudienzentrale0941 7823401fhk-studienzentrum(at)csj.de